← Back to patent-cliff list
CAS 80180-27-4,13116-20-6,127-47-9,11098-51-4,7095-40-1
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetate
Codes: Astaxanthin-053
Application context (from source-drug indications)
营养失调AstaxanthinKnee arthritisAstaxanthinDiabetic neuropathyAstaxanthinStrokeAstaxanthin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Astaxanthin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetate→O15-Acetyl-3-hydroxyretinol→[(2E,4E,6E,8E)-9-(4-Hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7-dimethylnona-2,4,6,8-tetraen-1-yl](triphenyl)phosphanium hydrogen sulfate→[(2E,4E,6E,8E)-9-(4-Hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7-dimethylnona-2,4,6,8-tetraen-1-yl](triphenyl)phosphanium chloride→beta,beta-Carotene-3,3'-diol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.